Hong Kong stock exchange’s new regime permitting companies with dual-class shares to list came into effect on April 30. We asked four experts about the pros and cons of this change.
The city's exchange operator will accept applications from pre-revenue biotech companies and issuers with dual-class shares from next Monday, despite lingering concerns.
Hong Kong's exchange proposes allowing pre-revenue innovative companies with dual-class structures to list in the city, raising concerns about investor protection.
Activist investor David Webb accuses Ronald Arculli of undermining any effort by other exchanges or alternative trading systems to compete with Hong Kong Exchanges and Clearing.